Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH
| Autor: | Caroline de Godoi Rezende Costa Molino, Patricia O Chocano-Bedoya, Angélique Sadlon, Robert Theiler, John E Orav, Bruno Vellas, Rene Rizzoli, Reto W Kressig, John A Kanis, Sophie Guyonnet, Wei Lang, Andreas Egli, Heike A. Bischoff-Ferrari |
|---|---|
| Přispěvatelé: | University of Zurich, Bischoff-Ferrari, Heike A |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Male
Frailty 11221 Clinic for Geriatric Medicine 360 Soziale Probleme Sozialdienste 610 Medicine & health 2700 General Medicine General Medicine Europe Cross-Sectional Studies 360 Social problems & social services Polypharmacy Prevalence Humans Female Independent Living 610 Medizin und Gesundheit Aged |
| Zdroj: | de Godoi Rezende Costa Molino, Caroline; Chocano-Bedoya, Patricia O; Sadlon, Angélique; Theiler, Robert; Orav, John E; Vellas, Bruno; Rizzoli, Rene; Kressig, Reto W; Kanis, John A; Guyonnet, Sophie; Lang, Wei; Egli, Andreas; Bischoff-Ferrari, Heike A (2022). Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH. BMJ open, 12(4), e051881. BMJ Publishing Group 10.1136/bmjopen-2021-051881 |
| ISSN: | 0174-5263 |
| DOI: | 10.1136/bmjopen-2021-051881 |
| Popis: | ObjectiveTo investigate the prevalence of polypharmacy and characteristics associated with polypharmacy in older adults from seven European cities.DesignCross-sectional study of baseline data from DO-HEALTH.Setting and participantsDO-HEALTH enrolled 2157 community-dwelling adults age 70 and older from seven centres in Europe. Participants were excluded if they had major health problems or Mini-Mental State Examination Score Primary outcome measuresExtensive information on prescription and over-the-counter medications were recorded. Polypharmacy was defined as the concomitant use of five or more medications, excluding vitamins or dietary supplements. Bivariate and multivariable logistic regression was used to test the association of sociodemographic factors (age, sex, years of education, living situation and city) and health-related indicators (number of comorbidities, cognitive function, frailty status, body mass index (BMI), prior fall, self-rated health and smoking status) with polypharmacy.Results27.2% of participants reported polypharmacy ranging from 16.4% in Geneva to 60.8% in Coimbra. In the multivariable logistic regression analyses, older age (OR 1.07; 95% CI 1.04 to 1.10), greater BMI (OR 1.09; 95% CI 1.06 to 1.12) and increased number of comorbidities (OR 2.13; 95% CI 1.92 to 2.36) were associated with polypharmacy. Women were less likely to report polypharmacy than men (OR 0.65; 95% CI 0.51 to 0.84). In comparison to participants from Zurich, participants from Coimbra were more likely to report polypharmacy (OR 2.36; 95% CI 1.56 to 3.55), while participants from Geneva or Toulouse were less likely to report polypharmacy ((OR 0.36; 95% CI 0.22 to 0.59 and OR 0.64; 95% CI 0.42 to 0.96), respectively). Living situation, smoking status, years of education, prior fall, cognitive function, self-rated health and frailty status were not significantly associated with polypharmacy.ConclusionPolypharmacy is common among relatively healthy older adults, with moderate variability across seven European cities. Independent of several confounders, being a woman, older age, greater BMI and greater number of comorbidities were associated with increased odds for polypharmacy.Trial registration numberNCT01745263. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|